What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
David M. Jablons focuses on Cancer research, Wnt signaling pathway, Lung cancer, Immunology and Carcinogenesis.
His work carried out in the field of Cancer research brings together such families of science as Cell culture, Apoptosis, Survivin, Beta-catenin and Signal transduction.
His research investigates the connection between Wnt signaling pathway and topics such as Cell growth that intersect with problems in Cell biology, RNA interference, PDZ domain and Bioinformatics.
His Lung cancer study integrates concerns from other disciplines, such as Chromosome, Carcinoma, Epidermoid carcinoma and Vaccination.
His Carcinoma research is multidisciplinary, incorporating perspectives in Cancer, Growth factor receptor, Surgery and Oncology.
His studies in Carcinogenesis integrate themes in fields like Molecular biology, Gene silencing and Antibody.
His most cited work include:
- Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (1677 citations)
- Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion (404 citations)
- Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer (328 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Cancer research, Lung cancer, Internal medicine, Cancer and Oncology.
His Cancer research study combines topics from a wide range of disciplines, such as Mesothelioma, Wnt signaling pathway, Signal transduction, Carcinogenesis and Immunology.
His research integrates issues of Molecular biology and Gene silencing in his study of Signal transduction.
His Lung cancer study combines topics from a wide range of disciplines, such as Carcinoma, Surgery, Disease and Adenocarcinoma.
His research ties Endocrinology and Internal medicine together.
He combines subjects such as Radiology and Chemotherapy with his study of Oncology.
He most often published in these fields:
- Cancer research (39.95%)
- Lung cancer (31.37%)
- Internal medicine (23.32%)
What were the highlights of his more recent work (between 2015-2021)?
- Cancer research (39.95%)
- Lung cancer (31.37%)
- Cancer (20.91%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Cancer research, Lung cancer, Cancer, Internal medicine and Oncology.
His Cancer research research is multidisciplinary, incorporating elements of Hippo signaling pathway, Cancer stem cell, Carcinogenesis, non-small cell lung cancer and Metastasis.
The subject of his Lung cancer research is within the realm of Pathology.
His Cancer research is multidisciplinary, incorporating perspectives in Molecular biology, Computational biology and DNA sequencing.
When carried out as part of a general Internal medicine research project, his work on Stage, Cohort, Clinical trial and Lung cancer staging is frequently linked to work in TNM staging system, therefore connecting diverse disciplines of study.
His study on Oncology also encompasses disciplines like
- Adenocarcinoma and related Lung, Tyrosine-kinase inhibitor and Neoadjuvant therapy,
- Mesothelioma and related Survival rate, Mortality rate and Surgery.
Between 2015 and 2021, his most popular works were:
- Mesothelioma: Scientific clues for prevention, diagnosis, and therapy. (106 citations)
- Lung Cancer Staging and Prognosis (90 citations)
- YAP promotes erlotinib resistance in human non-small cell lung cancer cells (56 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
The scientist’s investigation covers issues in Cancer research, Metastasis, Internal medicine, Oncology and Lung cancer.
The study incorporates disciplines such as Cancer cell, Cancer, Cancer stem cell, Hippo signaling pathway and non-small cell lung cancer in addition to Cancer research.
His Metastasis research includes elements of Carcinogenesis, Cell cycle and Cell migration.
His studies deal with areas such as Tunica vaginalis and Pleural mesothelioma as well as Internal medicine.
His studies in Oncology integrate themes in fields like Survival rate, Multimodality Treatment and Aggressive cancer.
His Lung cancer research is included under the broader classification of Pathology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
